Santo Domingo, RD.
The Dominican Governor announced the acquisition of the 110-mile dose of the Covishield vaccine, developed in India by AstraZeneca. It is hoped that this will be the first lot to go to the Dominican Republic in March.
What are the characteristics of this car?
This vaccine is a debilitated version of a common virus virus known as adenovirus in children. It has been modified to look more closely at coronavirus, although it can cause infections while the immunological system is producing anticonvulsants and preparing them to attack the coronavirus infection, according to the BBC.
For an effective mayor to require a dose dispensary, the first injection should take up to 12 weeks for the second inoculation.
The BBC article establishes that its manufacturer must be subjected to a refrigeration of 2 ° C to 8 ° C, the series of temperatures that refrigerate a non-domestic, which makes it easy to apply in any environment.
This represents a front end to the Pfizer-BioNTech vehicle, which needs to be raised to -70 ° C, so that for the preservation of this market, it is necessary to purchase special container containers that Covishield does not need.
Covishield / ChAdOx1nCoV-19 Corona Virus Vaccine – Recombinant es producida por Oxford-AstraZeneca and el Serum Institute of India, which the mayor manufactures from the vacuum of the mondo with the creation of the 50 millone per dose.
The international clinical trials of the vaccine demonstrate that when the individuals receive a dose of media and place a complete dose, the efficiency increases by 90%. But do not have enough clear dates to approve the idea of complete dosing and dosing.
The vaccine was approved for emergence, and the Dominican Gobierno hopes that the Serum Institute of India will be the first case to increase the dose in the country, although it will not be clear in March.
The first to receive this vacancy, according to the Dominican authorities, has a range of 12,500 first-line workers in the health care sector, which is comprised of 210 million people.
The vaccine produced in India and authorized by 12 sanitary authorities worldwide, was approved by the National Administration of Medicines, Food and Medical Technology (Anmat).
Other countries that are registered to buy
Ya Bután, Maldives, Bangladesh, Nepal, Myanmar and the Seychelles, and the resibido la vacuna India Covishield.
Covishield’s distributors have sent their vans as shelves and other doses for commercial purposes.
In June of this year, AstraZeneca announced a licensing agreement with Serum for the sum of millions of doses for low and medium-sized countries, with the compromise of proportioning 400 million before the 2020 finals.
También also intends to send doses to Sri Lanka, Afghanistan and Mauritius after the regulatory authorizations of these countries. También also authorized the commercial exports of the Covishield vehicle to Brazil.
India is a spruce producer of medicines and also vacancies with proper investigation.
Grupo Nacional Experto para Administración de la Vacuna contra la COVID-19 en agosto 2020 is created with the goal of coordinating the contracting and distribution of vacuens quienes dia de hoy tienen advansados tres proyectos: Covaxin, desarroliada con Bh Indian Council for Medical Investigation (CMR, in English); ZyCOV-D, developed by Zydus Cadila, which hopes to produce more than 100 million doses; and lastly, Covishield, approved this March by the Governor.